Skip to content
OpenCapital
Get started

Shattuck Labs, Inc. STTK Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

Immunovant, Inc. logo
Immunovant, Inc.IMVT
——

Other financials

Income statement

See full
Revenue-—
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K—
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0×0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s share based compensation arrangement by share based payment award options exercisable number?
Shattuck Labs, Inc. (STTK) reported share based compensation arrangement by share based payment award options exercisable number of $5.1M in Q1 2026.
How has Shattuck Labs, Inc.'s share based compensation arrangement by share based payment award options exercisable number changed year-over-year?
Shattuck Labs, Inc.'s share based compensation arrangement by share based payment award options exercisable number increased by 43.8% year-over-year, from $3.54M to $5.1M.
What is the long-term trend for Shattuck Labs, Inc.'s share based compensation arrangement by share based payment award options exercisable number?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s share based compensation arrangement by share based payment award options exercisable number has grown at a 37.9% compound annual growth rate (CAGR), from $868.78K to $4.33M.